The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review

The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review

Bao-Dong Qin,* Xiao-Dong Jiao,* Ling-Yan Yuan,* Ke Liu, Zhan Wang, Wen-Xing Qin, Yuan-Sheng Zang Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai 200072, China *These authors contributed equally to this work Abstract: In patients without tissue availability...

Full description

Bibliographic Details
Main Authors: Qin BD, Jiao XD, Yuan LY, Liu K, Wang Z, Qin WX, Zang YS
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:OncoTargets and Therapy
Subjects:
non-small cell lung cancer
cell-free DNA
EGFR mutation
afatinib
osimertinib
Online Access:https://www.dovepress.com/the-effectiveness-of-afatinib-and-osimertinib-in-a-chinese-patient-wit-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/the-effectiveness-of-afatinib-and-osimertinib-in-a-chinese-patient-wit-peer-reviewed-article-OTT

Similar Items